文献速递神经肿瘤

多祖先全基因组关联研究:4069例儿童胶质瘤识别9p21.3风险位点

Multi-ancestry genome-wide association study of 4069 children with glioma identifies 9p21.3 risk locus.
PubMed 文献 · Neuro Oncol · 2023-01-01

该研究对3项基于人群的全基因组关联研究进行荟萃分析,纳入4069例儿童胶质瘤和8778例多遗传祖先对照,并在独立病例对照队列中验证。结果显示9p21.3区CDKN2B-AS1常见变异与星形细胞瘤显著相关(rs573687,P=6.974e-10,OR 1.273,95%CI 1.179-1.374),且与脑组织CDKN2B表达降低相关。

要点

  • 9p21.3区CDKN2B-AS1常见变异与儿童星形细胞瘤显著相关(rs573687,P=6.974e-10,OR 1.273,95%CI 1.179-1.374)。
  • 该关联由低级别星形细胞瘤驱动(P=3.815e-9),在全部6个遗传祖先中效应方向一致。
  • 预测的脑组织CDKN2B表达降低与星形细胞瘤显著相关(P=8.090e-8)。

核心结论

  • 该基于人群的全基因组关联研究荟萃分析识别并验证9p21.3(CDKN2B-AS1)为儿童星形细胞瘤风险位点,首次提供儿童神经肿瘤中常见变异易感性的全基因组显著证据。
  • 研究通过显示与脑组织CDKN2B表达降低的可能联系提供功能基础,并证实低级别与高级别星形细胞瘤的遗传易感性不同。

研究设计与样本

  • 3项基于人群的全基因组关联研究的荟萃分析,纳入4069例儿童胶质瘤和8778例多遗传祖先对照。
  • 在独立病例对照队列中进行验证。
  • 进行数量性状位点分析和转录组关联研究,评估与18 628个基因的脑组织表达的可能联系。

主要发现

  • 9p21.3区CDKN2B-AS1常见变异与星形细胞瘤显著相关(rs573687,P=6.974e-10,OR 1.273,95%CI 1.179-1.374)。
  • 该关联由低级别星形细胞瘤驱动(P=3.815e-9),在全部6个遗传祖先中呈现单向效应。
  • 对于全部胶质瘤,该关联接近全基因组显著性(rs3731239,P=5.411e-8),而高级别肿瘤未观察到显著关联。
  • 预测的脑组织CDKN2B表达降低与星形细胞瘤显著相关(P=8.090e-8)。

关键数值与推荐

  • 星形细胞瘤关联:rs573687,P=6.974e-10,OR 1.273,95%CI 1.179-1.374。
  • 低级别星形细胞瘤关联:P=3.815e-9。
  • 全部胶质瘤关联:rs3731239,P=5.411e-8。
  • 脑组织CDKN2B表达降低与星形细胞瘤关联:P=8.090e-8。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although recent sequencing studies have revealed that 10% of childhood gliomas are caused by rare germline mutations, the role of common variants is undetermined and no genome-wide significant risk loci for pediatric central nervous system tumors have been identified to date. METHODS: Meta-analysis of 3 population-based genome-wide association studies comprising 4069 children with glioma and 8778 controls of multiple genetic ancestries. Replication was performed in a separate case-control cohort. Quantitative trait loci analyses and a transcriptome-wide association study were conducted to assess possible links with brain tissue expression across 18 628 genes. RESULTS: Common variants in CDKN2B-AS1 at 9p21.3 were significantly associated with astrocytoma, the most common subtype of glioma in children (rs573687, P-value of 6.974e-10, OR 1.273, 95% CI 1.179-1.374). The association was driven by low-grade astrocytoma (P-value of 3.815e-9) and exhibited unidirectional effects across all 6 genetic ancestries. For glioma overall, the association approached genome-wide significance (rs3731239, P-value of 5.411e-8), while no significant association was observed for high-grade tumors. Predicted decreased brain tissue expression of CDKN2B was significantly associated with astrocytoma (P-value of 8.090e-8). CONCLUSIONS: In this population-based genome-wide association study meta-analysis, we identify and replicate 9p21.3 (CDKN2B-AS1) as a risk locus for childhood astrocytoma, thereby establishing the first genome-wide significant evidence of common variant predisposition in pediatric neuro-oncology. We furthermore provide a functional basis for the association by showing a possible link to decreased brain tissue CDKN2B expression and substantiate that genetic susceptibility differs between low- and high-grade astrocytoma.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Foss-Skiftesvik J, Li S, Rosenbaum A, et al. Multi-ancestry genome-wide association study of 4069 children with glioma identifies 9p21.3 risk locus. Neuro Oncol. 2023. PMID: 36810956. doi:10.1093/neuonc/noad042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。